Welcome to our dedicated page for Tilt Hldgs news (Ticker: TLLTF), a resource for investors and traders seeking the latest updates and insights on Tilt Hldgs stock.
TILT Holdings Inc. (TLLTF) generates a wide range of company news tied to its role as a global provider of cannabis business solutions. Its disclosures describe a portfolio that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, with a core focus on Jupiter Research LLC, a wholly owned subsidiary active in vaporization hardware design, research, development, manufacturing and distribution. News about TILT often highlights how these activities support cannabis brands and retailers across North America, South America, Israel and the European Union.
Recent announcements show that TILT’s news flow covers both operational performance and strategic restructuring. Earnings releases discuss quarterly financial and operating results, including revenue trends, gross margin dynamics and the impact of strategic shifts such as divesting plant-touching assets in Massachusetts and Ohio or transitioning parts of Jupiter’s business to a commission-based model. Operational updates also describe regulatory approvals, such as European Union medical device certification for a handheld liquid inhalation device developed by Jupiter, and agreements with partners like Curaleaf International for commercialization in medical markets.
Another important stream of news relates to capital structure and creditor arrangements. TILT has reported entering into secured note purchase agreements for bridge financing, receiving default notices from landlords on certain cultivation properties, and negotiating forbearance arrangements. The company has also issued multiple releases about its CCAA restructuring process in the Supreme Court of British Columbia, including the initial order granting creditor protection, the proposed plan of arrangement to take the company private, and notices of meetings for noteholders.
For users following TLLTF on this news page, the coverage provides a consolidated view of TILT’s financial results, restructuring milestones, asset sales, regulatory certifications and governance events such as shareholder meeting outcomes. Investors and observers can use this archive to trace how TILT’s strategy has evolved toward Jupiter-centered, asset-light operations and to understand the context behind its delisting and restructuring decisions.
TILT Holdings has amended its agreement to sell the White Haven facility in Pennsylvania, extending the investigational period to June 17, 2022. This extension allows additional time to complete due diligence, including environmental assessments and zoning reports, which were delayed. The White Haven facility, operational since January 2019, spans approximately 40,000 square feet and encompasses cultivation, processing, and manufacturing spaces. TILT aims to finalize this transaction by the end of the quarter.
TILT Holdings Inc. announced the launch of the Infinity vaporizer, developed in collaboration with Jupiter Research and Commonwealth Alternative Care. Available starting May 20, 2022, at CAC locations and Massachusetts dispensaries, the Infinity features 300mg of cannabis extracts and utilizes CCELL® Heat-not-Burn technology. This product offers two strain options: Cinderella 99 and LA Kush Cake. The launch follows a successful previous collaboration in Pennsylvania, aiming to expand TILT’s market presence in the cannabis sector.
TILT Holdings Inc. reported its Q1 2022 financial results, with revenue of $42.4 million, down from $46.8 million year-over-year. Gross profit declined to $9.4 million, representing a margin of 22%. The company's operating expenses increased to $10.4 million, resulting in adjusted EBITDA of $1.5 million. TILT also announced two sale leaseback transactions totaling $55 million, aimed at reducing debt by up to 50%. Despite challenges in sales volume and inflationary pressures, the company expects 2022 revenue growth of approximately 28% and continues to forge strong partnerships in the cannabis sector.
TILT Holdings announced an exclusive partnership with Black Buddha Cannabis to launch its products in Massachusetts and later expand into Pennsylvania. Black Buddha Cannabis, founded by Roz McCarthy, focuses on wellness through its unique product lines like Black Buddha Prepacks™ and fast-acting gummies. The collaboration aims to enhance social equity and support local black farmers. With cannabis sales hitting $1.6B in Massachusetts last year, this initiative positions TILT to capitalize on growing market opportunities while promoting community engagement.
TILT Holdings Inc. (OTCQX: TLLTF), a leader in cannabis solutions, announced its participation in several upcoming investor conferences. Notable events include the Alliance Global Partners Spring Consumer Cannabis Conference on May 3, 2022, where management will engage in one-on-one meetings, and the Canaccord Genuity Cannabis Conference on May 11, 2022, featuring a presentation by CEO Gary Santo. Additionally, Santo will join a panel at the Wolfe Research Virtual Consumer Conference on May 13, 2022. For details on webcasts and presentations, visit TILT's investor relations website.
TILT Holdings Inc. will host a conference call on May 16, 2022, at 5:00 p.m. Eastern Time to discuss its Q1 2022 financial results. The call will provide an opportunity for management to present the results followed by a question-and-answer session. Interested participants are encouraged to dial in 10 minutes early. The earnings report will precede the call, which will also be available for replay on TILT's investor relations website. TILT operates in the cannabis sector, offering solutions across various markets.
TILT Holdings has filed a Registration Statement on Form 10 with the SEC to register its common shares under the Exchange Act. This filing aims to align TILT with U.S. reporting standards, enhancing transparency for shareholders. CEO Gary Santo highlighted the importance of this step towards growth and federal legalization. Upon effectiveness, TILT will adhere to Exchange Act reporting requirements, including financial results in U.S. GAAP. The Form 10 is also available on SEC's website and SEDAR.
Summary not available.
TILT Holdings has announced its participation in major cannabis conferences in April 2022. CEO Gary Santo will speak at the Cantor Investor Conference on April 14 and the Benzinga Cannabis Capital Conference on April 20. The company will also hold one-on-one investor meetings at these events. Additionally, Santo will appear on the MJ Stock Trader Podcast on April 4 and Benzinga’s Cannabis Insider on April 7. TILT Holdings focuses on providing cannabis business solutions across various sectors, including cultivation and retail.
TILT Holdings reported strong financial results for Q4 and FY 2021, with revenues up 28% YoY to $54.1 million and $202.7 million, respectively. Adjusted EBITDA for Q4 increased to $4.8 million, while FY 2021 adjusted EBITDA rose 33% to $22.5 million. The company expanded its operations significantly, launching new dispensaries and increasing its cultivation capacity. However, gross margins declined due to higher freight costs and customer mix. Looking ahead, TILT anticipates 2022 revenues between $255-$265 million, marking potential growth despite external market pressures.